InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score35
United States Fiscal year ends December CIK 0000728387
$2.66 -1.85% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.66 +351.31% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue4.8Operating income−6.3Net income−6.2Fiscal year 2018Revenue5.9 +24.4%Operating income−6.7Net income−6.7Fiscal year 2019Revenue7.3 +23.5%Operating income−5.3Net income−5.1Fiscal year 2020Revenue9.7 +32.3%Operating income−3.5Net income−3.4Fiscal year 2021Revenue10.1 +3.9%Operating income−3.4Net income−3.4Fiscal year 2022Revenue10.8 +7.4%Operating income−6.4Net income−7.3Fiscal year 2022Revenue0.0 −100.0%Operating income−8.7Net income−10.8Fiscal year 2023Revenue1.4Operating income−40.9Net income−46.5EPS, diluted−1.74Fiscal year 2024Operating income−90.9Net income−79.3EPS, diluted−1.23Fiscal year 2025Operating income−113.6Net income−103.1EPS, diluted−1.40
FY2017FY2018FY2019FY2020FY2021FY2022FY2022FY2023FY2024FY2025
Revenue 4.8 5.9 7.3 9.7 10.1 10.8 0.0 1.4 n/a n/a
Growth +24.4% +23.5% +32.3% +3.9% +7.4% −100.0%
Operating income −6.3 −6.7 −5.3 −3.5 −3.4 −6.4 −8.7 −40.9 −90.9 −113.6
Net income −6.2 −6.7 −5.1 −3.4 −3.4 −7.3 −10.8 −46.5 −79.3 −103.1
Growth
EPS, diluted n/a n/a n/a n/a n/a n/a n/a −1.74 −1.23 −1.40

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin17.6%Operating margin−132.5%Net margin−129.4%Free cash flow margin−131.5%Fiscal year 2018Gross margin31.1%Operating margin−113.6%Net margin−113.1%Free cash flow margin−102.1%Fiscal year 2019Gross margin41.7%Operating margin−71.8%Net margin−70.3%Free cash flow margin−75.1%Fiscal year 2020Gross margin52.9%Operating margin−35.9%Net margin−35.6%Free cash flow margin−40.4%Fiscal year 2021Gross margin50.9%Operating margin−34.3%Net margin−33.7%Free cash flow margin−32.0%Fiscal year 2022Gross margin0.0%Operating margin−59.5%Net margin−67.4%Free cash flow margin−73.9%Fiscal year 2022Fiscal year 2023Gross margin100.0%Operating margin−2,855.0%Net margin−3,243.2%Free cash flow margin−2,648.9%Fiscal year 2024Fiscal year 2025
FY2017FY2018FY2019FY2020FY2021FY2022FY2022FY2023FY2024FY2025
Gross margin 17.6% 31.1% 41.7% 52.9% 50.9% 0.0% n/a 100.0% n/a n/a
Operating margin −132.5% −113.6% −71.8% −35.9% −34.3% −59.5% n/a −2,855.0% n/a n/a
Net margin −129.4% −113.1% −70.3% −35.6% −33.7% −67.4% n/a −3,243.2% n/a n/a
Free cash flow margin −131.5% −102.1% −75.1% −40.4% −32.0% −73.9% n/a −2,648.9% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−5.7Capital expenditure−0.5Free cash flow−6.3Fiscal year 2018Operating cash flow−5.7Capital expenditure−0.3Free cash flow−6.0Fiscal year 2019Operating cash flow−5.0Capital expenditure−0.4Free cash flow−5.5Fiscal year 2020Operating cash flow−3.6Capital expenditure−0.3Free cash flow−3.9Fiscal year 2021Operating cash flow−2.8Capital expenditure−0.4Free cash flow−3.2Fiscal year 2022Operating cash flow−7.7Capital expenditure−0.3Free cash flow−8.0Fiscal year 2022Operating cash flow−10.4Capital expenditure−0.3Free cash flow−10.7Fiscal year 2023Operating cash flow−36.9Capital expenditure−1.1Free cash flow−38.0Fiscal year 2024Operating cash flow−18.3Capital expenditure−54.4Free cash flow−72.7Fiscal year 2025Operating cash flow−82.5Capital expenditure−12.7Free cash flow−95.2
FY2017FY2018FY2019FY2020FY2021FY2022FY2022FY2023FY2024FY2025
Operating cash flow −5.7 −5.7 −5.0 −3.6 −2.8 −7.7 −10.4 −36.9 −18.3 −82.5
Capital expenditure −0.5 −0.3 −0.4 −0.3 −0.4 −0.3 −0.3 −1.1 −54.4 −12.7
Free cash flow −6.3 −6.0 −5.5 −3.9 −3.2 −8.0 −10.7 −38.0 −72.7 −95.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash5.9Shareholders’ equity10.6Fiscal year 2018Cash2.6Shareholders’ equity5.0Fiscal year 2019Cash5.3Shareholders’ equity7.7Fiscal year 2020Cash2.4Shareholders’ equity5.7Fiscal year 2021Cash63.8Shareholders’ equity67.4Fiscal year 2022Cash55.9Shareholders’ equity61.3Fiscal year 2022Cash21.0Shareholders’ equity54.6Fiscal year 2023Cash9.2Total debt1.7Net cash (debt)7.5Shareholders’ equity75.2Debt to equity0.02Fiscal year 2024Cash61.6Total debt1.7Net cash (debt)59.9Shareholders’ equity290.7Debt to equity0.01Fiscal year 2025Cash30.6Total debt1.6Net cash (debt)29.0Shareholders’ equity207.0Debt to equity0.01
FY2017FY2018FY2019FY2020FY2021FY2022FY2022FY2023FY2024FY2025
Cash 5.9 2.6 5.3 2.4 63.8 55.9 21.0 9.2 61.6 30.6
Total debt n/a n/a n/a n/a n/a n/a n/a 1.7 1.7 1.6
Net cash (debt) n/a n/a n/a n/a n/a n/a n/a 7.5 59.9 29.0
Shareholders’ equity 10.6 5.0 7.7 5.7 67.4 61.3 54.6 75.2 290.7 207.0
Debt to equity n/a n/a n/a n/a n/a n/a n/a 0.02 0.01 0.01

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022 30 Jun 2022 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
4.8 5.9 7.3 9.7 10.1 10.8 0.0 1.4 n/a n/a
Growth +24.4% +23.5% +32.3% +3.9% +7.4% −100.0%
3.9 4.1 4.3 4.6 4.9 6.2 n/a n/a n/a n/a
0.8 1.8 3.0 5.1 5.1 0.0 0.0 1.4 n/a n/a
Growth +119.8% +65.4% +68.2% −0.1% −100.0%
1.0 1.7 1.5 1.1 1.4 0.9 0.9 21.3 41.6 84.2
3.9 4.2 4.2 4.6 4.7 5.6 7.5 21.1 26.6 30.2
−6.3 −6.7 −5.3 −3.5 −3.4 −6.4 −8.7 −40.9 −90.9 −113.6
Growth
n/a n/a n/a n/a n/a −6.3 −8.1 −40.1 −80.4 −104.4
0.0 0.0 0.0 0.0 0.0 0.0 0.0 −2.7 −2.1 −0.8
−6.2 −6.7 −5.1 −3.4 −3.4 −7.3 −10.8 −46.5 −79.3 −103.1
Growth
Per share
n/a n/a n/a −0.05 −0.03 −0.05 −0.08 −1.74 −1.23 −1.40
n/a n/a n/a n/a n/a n/a n/a −1.74 −1.23 −1.40
Growth
n/a n/a n/a 67.6 103.8 142.0 142.1 26.8 64.4 73.8
n/a n/a n/a n/a n/a n/a n/a 26.8 64.4 73.8
Growth +140.7% +14.6%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 27.8% a year over five years.
  • Operating margin is down 2,783.2 points on five years ago, at -2,855.0%.
  • A net loss in 10 of 10 years on file.